Who Formulates New Drug Treatment For Children

The World Health Organisation(WHO) has disclosed plans for new child care  formulations.
The new programme if approved will drive innovations for better paediatric medicines.
The world health apex body since 2015 has reported decline in infant and child mortality but observed that there is a lack of research into new life-saving tools targeted at children.
This  it said is partly due to the complexity of conducting studies including the youngest age groups.
“Children cannot swallow tablets or capsules, often cannot bear the taste of liquid medicines and metabolise drugs differently as they develop and grow.”
New drugs formulations is aimed at making  medicines palatable, scored, crushable, dispersible (i.e. disintegrates quickly in water), chewable, sprinkled on food orr mixed with breast milk.
Stressing the need to  improve the lives of infants and children , WHO stated that most drugs are not quality assured, especiallyin low income countries.
Once this is acheived it noted that it will help drive Sustainable Development Goals (SDG), particularly SDG 3, for good health and wellbeing, and the related target to achieve Universal Health Coverage (UHC) by 2030.
Already, GAP-f network partners are working together to remove barriers to developing and delivering appropriate, quality, affordable and accessible medicines for children.